Idenix Pharmaceuticals to Present at an Upcoming Investor Conference

Sep 14, 2011, 16:05 ET from Idenix Pharmaceuticals, Inc.

CAMBRIDGE, Mass., Sept. 14, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), announced today that Idenix management will present a corporate overview at the UBS Global Life Sciences Conference on September 21, 2011 at 2:00 p.m. ET at the Grand Hyatt, New York City.  

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contacts: Kelly Barry (617) 995-9033 (media) Eric Hoffman (617) 224-4485 (investors)

SOURCE Idenix Pharmaceuticals, Inc.



RELATED LINKS

http://www.idenix.com